Ergoteles’s Dentsply Sirona XRAY Stock Holding History

Ergoteles’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-23,600	Closed	-$1.24M	–	1098
2020 Q4	$1.24M	Buy	23,600 +17,200	+269%	+$848K	0.04%	298
2020 Q3	$280K	Buy	+6,400	New	+$283K	0.04%	369

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ergoteles's XRAY Position: Q1 2021 in Review

Ergoteles sold out of Dentsply Sirona (XRAY) in Q1 2021, closing a stake of 23,600 shares — an estimated $1.24M sold.

Ergoteles first reported a position in XRAY in Q3 2020 and held it in 2 quarters. The position peaked at $1.24M in Q4 2020. 540 funds tracked by Wall St. Rank hold XRAY as of Q1 2021.

Ergoteles reported no remaining Dentsply Sirona position as of Q1 2021 after selling out during the quarter.
Ergoteles sold 23,600 Dentsply Sirona shares in Q1 2021, an estimated $1.24M.
Ergoteles first reported a position in Dentsply Sirona in Q3 2020 and held it in 2 quarters.
Ergoteles's Dentsply Sirona position peaked at $1.24M in Q4 2020.
540 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2021.

Based on Ergoteles's 13F filing for Q1 2021, filed 12 May 2021.